Alpha 2.0
Login Register
» Articles » PMID: 170131

Regulation of Protein Kinase and Phosphoprotein Phosphatase by Cyclic AMP and Cyclic AMP Antagonist

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 1975 Sep 1
PMID 170131
Citations 4
Authors
H K Wasner
Affiliations
Soon will be listed here.
Citing Articles

Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes.

Wasner H, Lessmann M, Conrad M, Amini H, Psarakis E Acta Diabetol. 1996; 33(2):126-38.

PMID: 8870815 DOI: 10.1007/BF00569423.

The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone-stimulated synthesis and identification as prostaglandylinositol cyclic phosphate.

Wasner H, Salge U, Gebel M Acta Diabetol. 1993; 30(4):220-32.

PMID: 8180414 DOI: 10.1007/BF00569933.

Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action.

Wasner H, Weber S, Partke H Acta Diabetol. 1994; 31(4):175-82.

PMID: 7888687 DOI: 10.1007/BF00571947.

Thyrotropin-induced increase in phosphoprotamine phosphatase activity in rat thyroid.

Roques M, Tirard A J Endocrinol Invest. 1980; 3(2):119-23.

PMID: 6248588 DOI: 10.1007/BF03348237.